Sierra Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SRRA and buy or sell other stocks, ETFs, and their options commission-free!

About SRRA

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. 

CEO
Stephen George Dilly, PhD
CEOStephen George Dilly, PhD
Employees
Employees
Headquarters
San Mateo, California
HeadquartersSan Mateo, California
Founded
2003
Founded2003
Employees
Employees

SRRA Key Statistics

Market cap
1.34B
Market cap1.34B
Price-Earnings ratio
-8.13
Price-Earnings ratio-8.13
Dividend yield
Dividend yield
Average volume
583.08K
Average volume583.08K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$55.19
52 Week high$55.19
52 Week low
$14.91
52 Week low$14.91

People also own

Based on the portfolios of people who own SRRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.